RTA Laboratuvarlari Biyolojik (RTALB) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.010x

Based on the latest financial reports, RTA Laboratuvarlari Biyolojik (RTALB) has a cash flow conversion efficiency ratio of 0.010x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL20.98 Million ≈ $469.96K USD) by net assets (TL2.12 Billion ≈ $47.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

RTA Laboratuvarlari Biyolojik - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how RTA Laboratuvarlari Biyolojik's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does RTA Laboratuvarlari Biyolojik carry for a breakdown of total debt and financial obligations.

RTA Laboratuvarlari Biyolojik Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RTA Laboratuvarlari Biyolojik ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Revoil S.A AT:REVOIL	-0.040x
Vince Holding Corp NYSE:VNCE	0.085x
Avonmore Capital & Management Services Limited NSE:AVONMORE	0.003x
Bantas Bandirma Ambalaj Sanayi ve Ticaret AS IS:BNTAS	0.241x
Inspirisys Solutions Limited NSE:INSPIRISYS	0.278x
Brand 24 SA WAR:B24	0.338x
Artea SA PA:ARTE	-0.078x
EP Manufacturing Bhd KLSE:7773	0.090x

Annual Cash Flow Conversion Efficiency for RTA Laboratuvarlari Biyolojik (2010–2024)

The table below shows the annual cash flow conversion efficiency of RTA Laboratuvarlari Biyolojik from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see RTALB stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	TL1.67 Billion ≈ $37.38 Million	TL-84.45 Million ≈ $-1.89 Million	-0.051x	-212.98%
2023-12-31	TL1.62 Billion ≈ $36.21 Million	TL72.41 Million ≈ $1.62 Million	0.045x	+120.12%
2022-12-31	TL632.74 Million ≈ $14.17 Million	TL-140.82 Million ≈ $-3.15 Million	-0.223x	-211.06%
2021-12-31	TL343.23 Million ≈ $7.69 Million	TL68.78 Million ≈ $1.54 Million	0.200x	+258.87%
2020-12-31	TL167.81 Million ≈ $3.76 Million	TL9.37 Million ≈ $209.87K	0.056x	+35.39%
2019-12-31	TL86.69 Million ≈ $1.94 Million	TL3.58 Million ≈ $80.09K	0.041x	+140.54%
2018-12-31	TL57.06 Million ≈ $1.28 Million	TL-5.81 Million ≈ $-130.03K	-0.102x	-492.76%
2017-12-31	TL54.25 Million ≈ $1.22 Million	TL1.41 Million ≈ $31.47K	0.026x	-54.53%
2016-12-31	TL50.20 Million ≈ $1.12 Million	TL2.86 Million ≈ $64.05K	0.057x	-56.95%
2015-12-31	TL46.74 Million ≈ $1.05 Million	TL6.18 Million ≈ $138.52K	0.132x	+92.92%
2014-12-31	TL37.64 Million ≈ $843.11K	TL2.58 Million ≈ $57.83K	0.069x	-87.31%
2013-12-31	TL20.83 Million ≈ $466.61K	TL11.26 Million ≈ $252.28K	0.541x	+165.77%
2012-12-31	TL10.99 Million ≈ $246.17K	TL2.24 Million ≈ $50.08K	0.203x	+28.71%
2011-12-31	TL10.19 Million ≈ $228.27K	TL1.61 Million ≈ $36.08K	0.158x	-34.75%
2010-12-31	TL11.46 Million ≈ $256.76K	TL2.78 Million ≈ $62.20K	0.242x	--

About RTA Laboratuvarlari Biyolojik

IS:RTALB Turkey Biotechnology

Market Cap

$37.07 Million

TL1.66 Billion TRY

Market Cap Rank

#22971 Global

#408 in Turkey

Share Price

TL3.31

Change (1 day)

+1.85%

52-Week Range

TL2.60 - TL4.52

All Time High

TL29.60